# Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer

> **NCT00791336** · PHASE2 · TERMINATED · sponsor: **University of Iowa** · enrollment: 1 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** Nelfinavir

## Key facts

- **NCT ID:** NCT00791336
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-08
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Poor enrollment.
- **Last updated:** 2017-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00791336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00791336, "Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00791336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*